Posted: 6 hours ago / Oct. 30, 2025 5:32 p.m. UTC
Earnings Shock: FMC Corporation’s stock has taken a significant hit recently, with shares plummeting over 40% following disappointing third-quarter results. Discussions on X highlight a major write-down in its India business and a slashed dividend as key triggers for the drop. Investors are reeling from the unexpected downturn as reported in recent posts.
Future Concerns: Sentiment on X also focuses on FMC’s lowered 2025 profit forecast and ongoing challenges with generic competition in its insecticide segment. Many express worry over the company’s $4 billion debt and negative cash flow issues, with some users cautioning against long positions. The abrupt leadership change adds another layer of uncertainty to the conversation.
Mixed Reactions: While the mood is largely negative, a few voices on X suggest potential for recovery if market conditions like lower mortgage rates play in FMC’s favor. However, most discussions reflect skepticism about the company’s near-term growth prospects. The sharp decline has sparked intense debate over the stock’s future direction.
Note: This discussion summary was generated from an AI condensation of post data.
FMC Corporation Insider Trading Activity
FMC Corporation insiders have traded $FMC stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $FMC stock by insiders over the last 6 months:
- JACQUELINE SCANLAN (Executive VP & Chief HRO) has made 0 purchases and 2 sales selling 5,300 shares for an estimated $185,469.
To track insider transactions, check out Quiver Quantitative’s insider trading dashboard.
FMC Corporation Congressional Stock Trading
Members of Congress have traded $FMC stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FMC stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard.
FMC Corporation Hedge Fund Activity
We have seen 223 institutional investors add shares of FMC Corporation stock to their portfolio, and 299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 1,914,490 shares (+119.1%) to their portfolio in Q2 2025, for an estimated $79,929,957
- UBS GROUP AG added 1,403,769 shares (+116.4%) to their portfolio in Q2 2025, for an estimated $58,607,355
- ILEX CAPITAL PARTNERS (UK) LLP added 1,261,784 shares (+inf%) to their portfolio in Q2 2025, for an estimated $52,679,482
- CAPITAL INTERNATIONAL INVESTORS added 1,232,705 shares (+inf%) to their portfolio in Q2 2025, for an estimated $51,465,433
- MILLENNIUM MANAGEMENT LLC added 1,215,758 shares (+147.6%) to their portfolio in Q2 2025, for an estimated $50,757,896
- AQR CAPITAL MANAGEMENT LLC removed 1,058,975 shares (-29.2%) from their portfolio in Q2 2025, for an estimated $44,212,206
- AMERICAN CENTURY COMPANIES INC added 899,013 shares (+177.2%) to their portfolio in Q2 2025, for an estimated $37,533,792
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard.
FMC Corporation Analyst Ratings
Wall Street analysts have issued reports on $FMC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a “Buy” rating on 10/22/2025
- Wells Fargo issued a “Overweight” rating on 10/16/2025
To track analyst ratings and price targets for FMC Corporation, check out Quiver Quantitative’s $FMC forecast page.
FMC Corporation Price Targets
Multiple analysts have issued price targets for $FMC recently. We have seen 10 analysts offer price targets for $FMC in the last 6 months, with a median target of $38.5.
Here are some recent targets:
- Benjamin Theurer from Barclays set a target price of $22.0 on 10/30/2025
- Vincent Andrews from Morgan Stanley set a target price of $38.0 on 10/22/2025
- Duffy Fischer from Goldman Sachs set a target price of $43.0 on 10/22/2025
- Richard Garchitorena from Wells Fargo set a target price of $41.0 on 10/16/2025
- Steve Byrne from B of A Securities set a target price of $33.0 on 10/14/2025
- Christopher Parkinson from Mizuho set a target price of $39.0 on 10/09/2025
- Joshua Spector from UBS set a target price of $36.0 on 10/06/2025
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
